This activity is provided by Paradigm Medical Communications, LLC.
This activity is supported by independent educational grants from Boehringer Ingelheim Pharmaceuticals, Inc and Sunovion Pharmaceuticals Inc.
Chronic obstructive pulmonary disease (COPD), a respiratory disease with heterogeneous presentations, can be difficult to identify amidst the long and varied list of conditions competing for internal medicine clinicians’ (IMs’) time and attention in daily clinical practice. Once the diagnosis is made, treatment is complicated by a steady influx of both sophisticated pharmacotherapies and devices. Contributing to the confusion, recent guideline updates call for significant practice changes based on compelling new data. This audio webinar, including patient simulations, will help internists wade through the different presentations of COPD and evolving treatments and devices to improve diagnosis and maximize outcomes for patients through appropriate treatment and device selection. This education will be instrumental in helping IMs stay current with advances in COPD that can significantly improve several important outcomes, including lung function, exacerbations, hospital admissions (and readmissions), and quality of life.
Table of Contents
1. Is This COPD?
2. Virtual Patient #1
3. Gauging Disease Severity, Treating Accordingly: Part 1
4. Virtual Patient #2
5. Gauging Disease Severity, Treating Accordingly: Part 2
This activity has been designed to address the educational needs of internal medicine clinicians, including internists, nurse practitioners, and PAs. It may also benefit family physicians, community pulmonologists, respiratory therapists, pharmacists, and other healthcare professionals engaged or interested in the care of patients with COPD.
Upon proper completion of this activity, participants should be better able to:
Identify early signs and symptoms of COPD that warrant further evaluation with guideline-recommended tools and tests
Describe evidence-based tools and strategies for determining the severity of COPD, including their utility in directing appropriate therapy
Select treatment options for COPD by applying information about agent, patient, and disease characteristics
Choose a medication delivery device for patients with COPD that accords with patient needs, preferences, and capabilities
Accreditor Disclosure of Conflicts of Interest Policy
In accordance with Accreditation Council for Continuing Medical Education requirements on disclosure, faculty and contributors are asked to disclose any relationships with commercial interests associated with the area of medicine featured in the activity. These relationships are described below.
Sandra G. Adams, MD, MS Professor of Medicine University of Texas Health San Antonio Pulmonary Diseases and Critical Care Medicine South Texas Veterans Health Care System San Antonio, TX
Dr. Adams discloses the following: Grant/Research Support: AstraZeneca; Boehringer Ingelheim Pharmaceuticals, Inc; Daiichi Sankyo, Inc; GlaxoSmithKline; Novartis; Sunovion Pharmaceuticals Inc
Brian W. Carlin, MD, FCCP, FAARC, MAACVPR Sleep Medicine and Lung Health Consultants Pittsburgh Critical Care Associates Pittsburgh, PA
Dr. Carlin discloses the following: Retained Consultant: GlaxoSmithKline Speakers Bureau: Monaghan Medical Corporation; Philips Respironics; Sunovion Pharmaceuticals Inc
Jeff Unger, MD, FAAFP, FACE Assistant Clinical Professor of Family Medicine UC Riverside School of Medicine Riverside, CA Director, Unger Concierge Primary Care Medical Group Rancho Cucamonga, CA
Dr. Unger discloses the following: No financial relationships to disclose.
Paradigm Medical Communications, LLC, staff members have no financial relationships to disclose.
Independent peer reviewer has no financial relationships to disclose.
Resolution of Conflict of Interest
Paradigm Medical Communications, LLC, has implemented a system to resolve conflicts of interest for each CME activity to help ensure content objectivity, independence, fair balance, and that the content is aligned with the interest of the public. Conflicts, if any, are resolved through one or more processes. All CME content in this activity was independently reviewed to ensure that it is free of commercial bias, scientifically rigorous, aligned with the public interest, and compliant with all regulatory guidance and the ACCME’s Standards for Commercial Support of Continuing Medical Education.
AMA PRA Category 1 Credit(s)TM
Paradigm Medical Communications, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Paradigm Medical Communications, LLC, designates this enduring material for a maximum of 2.00 AMA PRA Category 1 CreditsTM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PA Continuing Education
PAs may claim a maximum of 2.00 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 CreditTM from organizations accredited by ACCME or a recognized state medical society.
Nurse Practitioner Continuing Education
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA.
This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
If included, signed statements of informed consent granting permission for publication have been obtained for all photographs and videos in which an individual can be identified.
As an ACCME-accredited provider, Paradigm Medical Communications, LLC, activities must include a balanced view of therapeutic options. Use of generic names contributes to this impartiality. The use of trade names should not be viewed as an endorsement of specific products by Paradigm Medical Communications, LLC.
To receive a CME certificate of participation, participants must:
Follow the "Start Activity" button to go to the Paradigm Medical Communications website, where you will complete the pre-activity assessment.
View the online activity in its entirety.
Complete and submit the online post-activity assessment and evaluation.
A certificate of participation will be available for download/printing immediately following your successful completion of the post-activity assessment and evaluation. Your certificate will be saved on the Paradigm Medical Communications website and will not be available in your myCME CME History.
For questions regarding CME credit, contact the Paradigm CME Department at (845) 398-5949.
There is no fee required for participation in this activity.
This certified CME activity is designed using HTML5 audio. As you navigate using the supplied controls, the slides will sync to the speaker.
For Desktops (Windows/Mac) Internet Explorer 9 or higher, Firefox 28 or higher, Safari 5.1 or higher, Google Chrome 31 or higher, Opera 21 or higher
For Tablets (iPad/Android/Surface) iOS Safari 4 or higher, Android 2.3 or higher, IE Mobile 10 or higher
Disclaimer The materials provided for this activity are for informational purposes only, and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. Any views or opinions presented are solely those of the Faculty, and do not necessarily represent those of Paradigm Medical Communications, LLC. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by Paradigm Medical Communications, LLC. Paradigm Medical Communications, LLC, accepts no liability for the content referenced in this activity.
Security/safeguarding personal information This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.
Collection and use of your personal information The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CME activity. All evaluative information submitted is collected and retained, and used by Paradigm Medical Communications, LLC, to continuously improve the learning experience.
Paradigm Medical Communications, LLC, does not transfer, sell, or share personal information with outside parties. Paradigm Medical Communications, LLC, will not otherwise disclose personal information unless required to in a legal process. Paradigm Medical Communications, LLC, staff members review individual test results to the extent necessary to record and track participants’ credits.